Dental management in chronic liver disease depends on diagnosis, current liver function, portal hypertension, haemostasis, infection risk, medicines and transplant status. “Liver disease” is not one uniform risk category; dentists need current medical information before invasive or extensive treatment.
Contents
Liver-focused dental assessment
- Record the diagnosis, cause, severity, complications and hepatology contact.
- Clarify cirrhosis, portal hypertension, ascites, encephalopathy, varices and transplant status.
- Review medicines, alcohol use, bleeding history and recent relevant laboratory results.
- Assess active infection, periodontal disease, caries, candidiasis, mucosal lesions and nutrition.
- Coordinate invasive care when haemostasis, immunity, drug metabolism or medical stability is uncertain.
- Use standard infection prevention for every patient; do not stigmatise viral hepatitis.
Haemostasis, infection and healing
Cirrhosis can involve thrombocytopenia and complex coagulation changes that are not described fully by one test. Procedure type, bleeding history, platelet count, medical stability and local haemostatic options all matter. Active infection requires timely source control, while decompensated disease or transplantation may require specialist planning.
Clinical decision table
| Context | Concern | Response |
|---|---|---|
| Stable chronic liver disease, non-invasive care | Usually limited additional risk | Proceed after updated history |
| Cirrhosis with thrombocytopenia or bleeding history | Procedure-related haemorrhage | Obtain current medical assessment and haemostasis plan |
| Decompensation or encephalopathy | Medical instability and consent complexity | Coordinate or refer before elective care |
| Active viral hepatitis | Medical status and blood-borne infection | Use standard precautions and coordinate clinically |
| Liver transplant pathway | Infection and immunosuppression | Complete clearance and plan timing with transplant team |
Prescribing and local care
Hepatic impairment can alter the metabolism or safety of analgesics, sedatives, antibiotics and antifungals. Verify drug choice and dose using current hepatic prescribing guidance or pharmacist or hepatology advice. Do not independently stop anticoagulants or liver medicines. Use meticulous local haemostasis and appropriate review.
Related DentalReach reading
- hepatitis B and dental professionals
- bleeding-risk planning for extractions
- dental antibiotic stewardship
Frequently asked questions
Does an elevated INR alone define dental bleeding risk in cirrhosis?
No. Interpret it with disease status, platelets, bleeding history, procedure and specialist advice.
Do patients with viral hepatitis require separate infection-control measures?
No special category is needed. Apply standard precautions consistently to every patient.
Can routine dental doses always be used in liver disease?
No. Drug selection and dose may require modification according to hepatic function and interactions.